These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18219156)

  • 1. Anemia is an independent predictor for elevated plasma levels of natriuretic peptides in patients undergoing cardiac catheterization for coronary artery disease.
    Fukuta H; Ohte N; Mukai S; Saeki T; Kobayashi K; Kimura G
    Circ J; 2008 Feb; 72(2):212-7. PubMed ID: 18219156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
    Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease.
    Fukuta H; Ohte N; Mukai S; Saeki T; Asada K; Wakami K; Kimura G
    Int Heart J; 2009 May; 50(3):301-12. PubMed ID: 19506334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass.
    Chello M; Mastroroberto P; Perticone F; Cirillo F; Bevacqua E; Olivito S; Covino E
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):140-6. PubMed ID: 11423287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T; Mori Y; Ishimura K; Tadokoro K; Yagi H; Yabe A; Horinaka S; Matsuoka H
    Am J Med; 2004 Apr; 116(8):517-23. PubMed ID: 15063812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.
    Suda K; Matsumura M; Matsumoto M
    Pediatr Int; 2003 Jun; 45(3):249-54. PubMed ID: 12828576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
    Maeda K; Tsutamoto T; Wada A; Hisanaga T; Kinoshita M
    Am Heart J; 1998 May; 135(5 Pt 1):825-32. PubMed ID: 9588412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.
    Nagaya N; Nishikimi T; Okano Y; Uematsu M; Satoh T; Kyotani S; Kuribayashi S; Hamada S; Kakishita M; Nakanishi N; Takamiya M; Kunieda T; Matsuo H; Kangawa K
    J Am Coll Cardiol; 1998 Jan; 31(1):202-8. PubMed ID: 9426041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.
    Park MH; Scott RL; Uber PA; Harris BC; Chambers R; Mehra MR
    Am J Cardiol; 2002 Dec; 90(12):1326-9. PubMed ID: 12480042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.